FDA.reportPublic FDA data

everolimus 0.25 MG Oral Tablet

RxCUI
977427
RxNorm name
everolimus 0.25 MG Oral Tablet
Display name
everolimus 0.25 MG Oral Tablet
Full name
everolimus 0.25 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EverolimusEVEROLIMUS TABLETSBreckenridge Pharmaceutical, Inc.c7bb6ba1-9a7f-43f5-b058-ef26d4b592212026-07-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 977427
everolimusEVEROLIMUSAurobindo Pharma Limited43ef3c29-0e25-4fdd-aea1-06a20af9bbab2026-02-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 977427
ZortressEVEROLIMUSNovartis Pharmaceuticals Corporatione082a024-7850-400b-a5c2-2a140612562a2026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 977427
EverolimusEVEROLIMUSAscend Laboratories, LLC2693c497-a70b-4d00-b6db-602c872e5bed2025-12-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 977427
EverolimusEVEROLIMUSNatco Pharma Limitedd44998bb-5deb-4ee7-a0a5-979fe3f495572025-10-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 977427
EverolimusEVEROLIMUSBiocon Pharma Inc.435da284-ef0e-ca90-e0db-bab9382922e02025-05-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 977427
EverolimusEVEROLIMUSPar Health USA, LLC59cb86d5-8706-4619-b074-af253d3e0b682025-01-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 977427
EverolimusEVEROLIMUSHikma Pharmaceuticals USA Inc.cf2dd54b-7a1d-4401-9a01-75e68235e4332024-09-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 977427

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e082a024-7850-400b-a5c2-2a140612562aeverolimus 0.25 MG Oral Tablet [PSN] · everolimus 0.25 MG Oral Tablet [SCD]229These highlights do not include all the information needed to use ZORTRESS safely and effectively. See full prescribing information for ZORTRESS. ZORTRESS ® (everolimus) tablets, for oral use Initial U.S. Approval: 201020260212
59cb86d5-8706-4619-b074-af253d3e0b68everolimus 0.25 MG Oral Tablet [PSN] · everolimus 0.25 MG Oral Tablet [SCD]215These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 201020250113
2693c497-a70b-4d00-b6db-602c872e5bedeverolimus 0.25 MG Oral Tablet [PSN] · everolimus 0.25 MG Oral Tablet [SCD]29These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 201020251219
c7bb6ba1-9a7f-43f5-b058-ef26d4b59221everolimus 0.25 MG Oral Tablet [PSN] · everolimus 0.25 MG Oral Tablet [SCD]28These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 201020251104
cf2dd54b-7a1d-4401-9a01-75e68235e433everolimus 0.25 MG Oral Tablet [PSN] · everolimus 0.25 MG Oral Tablet [SCD]28These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 201020240903
435da284-ef0e-ca90-e0db-bab9382922e0everolimus 0.25 MG Oral Tablet [PSN] · everolimus 0.25 MG Oral Tablet [SCD]27These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 201020250530
d44998bb-5deb-4ee7-a0a5-979fe3f49557everolimus 0.25 MG Oral Tablet [PSN] · everolimus 0.25 MG Oral Tablet [SCD]25These highlights do not include all the information needed to use EVEROLIMUS tablets safely and effectively. See full prescribing information for EVEROLIMUS tablets. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 201020251014
43ef3c29-0e25-4fdd-aea1-06a20af9bbabeverolimus 0.25 MG Oral Tablet [PSN] · everolimus 0.25 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 201020260226